BRITTANY WASHINGTON: Open Payments
NPI 1538650270 · PELL CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,705 in 96 payments from 23 companies in 2025. Trend: 2023 $2,653 · 2024 $1,804 · 2025 $1,705
Food & beverage: $1,705
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $308 |
| Otsuka America Pharmaceutical, Inc. | 9 | $190 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $176 |
| GlaxoSmithKline, LLC. | 10 | $152 |
| Axsome Therapeutics, Inc. | 5 | $122 |
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| Almatica Pharma LLC | 4 | $88 |
| Exact Sciences Corporation | 4 | $75 |
| PFIZER INC. | 3 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
Products named: REXULTI, Kerendia, TRELEGY ELLIPTA, Auvelity, Ozempic, LOREEV XR, JARDIANCE, BREZTRI.
Industry payments across AL — which companies pay providers there.
